Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Dosing strategies for targeting EPCAM positive bladder cancer

Dosing strategies for targeting EPCAM positive bladder cancer

US Patent 10583198 · Granted Mar 10, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods of treatment for EpCAM positive bladder cancer2020
Methods of treatment for EpCAM positive bladder cancer2020
Anti-EPCAM antibodies and methods of use2017
Methods for generating and screening fusion protein libraries and uses thereof2015
Tumor specific antibody2015
Cancer-associated antigen2015
Cytotoxins comprising modified bouganin toxin for the treatment of cancer2014
Cancer specific antibody and cell surface proteins2014
Cancer-associated antigen2013
CD44E tumor specific antibody2013
Optimized nucleic acid sequences for the expression of VB4-8452012
Binding proteins that bind to EpCAM linked to an effector molecule2012